This trial is to test if new MRI and ultrasound techniques can detect cancer in the lining of the stomach better than current techniques.
- Peritoneal Mesotheliomas
2 Primary · 4 Secondary · Reporting Duration: 60 days
0 Treatment Group
24 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants are being allowed to take part in this trial?
"Affirmative. The records available on clinicaltrials.gov confirm that this medical research, which was initially posted in October 2018, is currently recruiting subjects. 24 participants will be admitted from a single study centre." - Anonymous Online Contributor
What goals are researchers attempting to accomplish with this clinical experiment?
"This 60-day trial aims to improve sensitivity of diagnosis using high resolution contrast enhanced MRI imaging sequences. Additionally, it will assess ultrasound elastography in order to ascertain optimal strain ratios and elasticity scores that can optimise accuracy for peritoneal mesothelioma patients. Finally, the experiment would test HD small-voxel MRIs focusing on right hemidiaphragmatic and pelvic spaces to detect malignant disease." - Anonymous Online Contributor
Is it still feasible to join this experimental endeavor?
"Affirmative, the information hosted by clinicaltrials.gov specifies that this trial is presently in search of candidates. This study was first denoted on October 10th 2018 and last modified on May 16th 2022; 24 patients are desired for enrollment at a single site." - Anonymous Online Contributor